195 related articles for article (PubMed ID: 11171788)
41. Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow.
French JK; Amos DJ; Williams BF; Cross DB; Elliott JM; Hart HH; Williams MG; Norris RM; Ashton NG; Whitlock RM; McLaughlin SC; White HD
J Am Coll Cardiol; 1999 Jan; 33(1):139-45. PubMed ID: 9935020
[TBL] [Abstract][Full Text] [Related]
42. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
[TBL] [Abstract][Full Text] [Related]
43. Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.
Parlakpinar H; Ozer MK; Acet A
Cytokine; 2011 Dec; 56(3):688-94. PubMed ID: 21975128
[TBL] [Abstract][Full Text] [Related]
44. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
Borghi C; Ambrosioni E;
Am Heart J; 2007 Mar; 153(3):445.e7-14. PubMed ID: 17307427
[TBL] [Abstract][Full Text] [Related]
45. Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction.
Schulman SP; Weiss JL; Becker LC; Guerci AD; Shapiro EP; Chandra NC; Siu C; Flaherty JT; Coombs V; Taube JC
Am J Cardiol; 1995 Oct; 76(11):764-70. PubMed ID: 7572651
[TBL] [Abstract][Full Text] [Related]
46. Limitation of left ventricular hypertrophy and dysfunction by ACE inhibition after anterior Q-wave myocardial infarction.
Jugdutt BI; Humen DP
Cardiology; 1998 May; 89(4):283-90. PubMed ID: 9643276
[TBL] [Abstract][Full Text] [Related]
47. Ventricular arrhythmias in the acute and chronic phases after acute myocardial infarction. Effect of intervention with captopril.
Søgaard P; Gøtzsche CO; Ravkilde J; Nørgaard A; Thygesen K
Circulation; 1994 Jul; 90(1):101-7. PubMed ID: 8025983
[TBL] [Abstract][Full Text] [Related]
48. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
Pfeffer MA; McMurray JJ; Velazquez EJ; Rouleau JL; Køber L; Maggioni AP; Solomon SD; Swedberg K; Van de Werf F; White H; Leimberger JD; Henis M; Edwards S; Zelenkofske S; Sellers MA; Califf RM;
N Engl J Med; 2003 Nov; 349(20):1893-906. PubMed ID: 14610160
[TBL] [Abstract][Full Text] [Related]
49. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction.
St John Sutton M; Lee D; Rouleau JL; Goldman S; Plappert T; Braunwald E; Pfeffer MA
Circulation; 2003 May; 107(20):2577-82. PubMed ID: 12732606
[TBL] [Abstract][Full Text] [Related]
50. [Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies].
Pfeffer MA; Braunvald Iu; Moĭe LA; Basta L; Braun EDzh ; Kaddi TE; Dévis BR; Geltman EM; Goldman S; Fleĭker GS
Kardiologiia; 1993; 33(12):14-23, 3. PubMed ID: 7910865
[TBL] [Abstract][Full Text] [Related]
51. Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a beta-blocker or a bradycardiac agent on their incidence.
Heidbüchel H; Tack J; Vanneste L; Ballet A; Ector H; Van de Werf F
Circulation; 1994 Mar; 89(3):1051-9. PubMed ID: 8124790
[TBL] [Abstract][Full Text] [Related]
52. Beneficial effect of enalapril on left ventricular remodelling in patients with a severe residual stenosis after acute anterior wall infarction.
Baur LH; Schipperheyn JJ; van der Wall EE; van der Velde EA; Schalij MJ; van Eck-Smit BL; van der Laarse A; Voogd PJ; Sedney MI; Reiber JH; Bruschke AV
Eur Heart J; 1997 Aug; 18(8):1313-21. PubMed ID: 9458425
[TBL] [Abstract][Full Text] [Related]
53. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension.
Buus NH; Bøttcher M; Jørgensen CG; Christensen KL; Thygesen K; Nielsen TT; Mulvany MJ
Hypertension; 2004 Oct; 44(4):465-70. PubMed ID: 15326083
[TBL] [Abstract][Full Text] [Related]
54. Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy.
Van de Werf F; Janssens L; Brzostek T; Mortelmans L; Wackers FJ; Willems GM; Heidbüchel H; Lesaffre E; Scheys I; Collen D
J Am Coll Cardiol; 1993 Aug; 22(2):407-16. PubMed ID: 8335810
[TBL] [Abstract][Full Text] [Related]
55. The combination ace-inhibitors plus canreonate in patients with anterior myocardial infarction: safety and tolerability study.
Di Pasquale P; Alessi V; Barberi O; Scandurra A; Bucca V; Maringhini G; Scalzo S; Paterna S
Int J Cardiol; 2001 Feb; 77(2-3):119-27; discussion 128-9. PubMed ID: 11182173
[TBL] [Abstract][Full Text] [Related]
56. Angiotensin-converting enzyme inhibitors in preventing remodeling and development of heart failure after acute myocardial infarction: results of the German multicenter study of the effects of captopril on cardiopulmonary exercise parameters (ECCE).
Kleber FX; Sabin GV; Winter UJ; Reindl I; Beil S; Wenzel M; Fischer M; Doering W
Am J Cardiol; 1997 Aug; 80(3A):162A-167A. PubMed ID: 9293972
[TBL] [Abstract][Full Text] [Related]
57. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
[TBL] [Abstract][Full Text] [Related]
58. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.
St John Sutton M; Pfeffer MA; Plappert T; Rouleau JL; Moyé LA; Dagenais GR; Lamas GA; Klein M; Sussex B; Goldman S
Circulation; 1994 Jan; 89(1):68-75. PubMed ID: 8281697
[TBL] [Abstract][Full Text] [Related]
59. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
60. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
